Abstract
We report on 8 patients treated with subcutaneous methadone for cancer-related pain at 2 institutions. The success of other subcutaneous agents for pain control has been well demonstrated. It was felt that methadone would be useful due to its low cost. Unfortunately, 7 of the 8 patients experienced adverse reactions at the subcutaneous sites requiring cessation of subcutaneous methadone.
Original language | English (US) |
---|---|
Pages (from-to) | 141-143 |
Number of pages | 3 |
Journal | Pain |
Volume | 45 |
Issue number | 2 |
DOIs | |
State | Published - May 1991 |
Externally published | Yes |
Keywords
- Cancer-related pain
- Methadone sc
- Toxicity
ASJC Scopus subject areas
- Neurology
- Clinical Neurology
- Anesthesiology and Pain Medicine